translation & commercialisation

Murdoch Childrens has a number of potential licensing opportunities available including rotavirus vaccine, medical devices, diagnostic targets and diagnostic assays for childhood diseases as well as diseases that extend into adulthood.

The Institute invites interested parties to take up the opportunity to invest in its wide portfolio of commercial biotechnologies.

Murdoch Childrens seeks investors and industry to actively develop value from its intellectual property through licensing, partnerships or contracting opportunity.

latest news

19 January 2012 - Murdoch Childrens Research Institute and Medical Research Commercialisation Fund launch GI Therapies Pty Ltd to develop a non‐invasive device to treat constipation....Read more>

current projects and opportunities:

• A New Methodology for the Prevention of Respiratory Complications
• New Medical Device for the Treatment of Diabetes Type I and II and Obesity
• RV3: A Rotavirus Vaccine for the Developing World
• IGFBP-2 mutant potently inhibits proliferation of neuroblastoma cells
• Development and evaluation of novel foetal Haemoglobin Inducers

Please contact the Business Development Manager for more details;  

Angeline Bartholomeusz                          
T +61 3 8341 6459
E angeline.b@mcri.edu.au